Combined therapy with interpersonal psychotherapy adapted for borderline personality disorder: A two-years follow-up.
Few investigations evaluated the long-term effects of psychotherapies in borderline personality disorder (BPD). In a previous study, we compared efficacy of combination of fluoxetine and interpersonal psychotherapy adapted to BPD (IPT-BPD) versus single fluoxetine administered for 32 weeks. This study is aimed to investigate whether the results obtained with the addition of IPT-BPD persist during a follow-up period. Forty-four patients who completed the 32 weeks trial underwent 24 months of follow-up receiving fluoxetine 20-40 mg/day. Clinical Global Impression Severity (CGI-S), Hamilton Rating Scales for Depression and Anxiety (HDRS, HARS), Social and Occupational Functioning Assessment Scale (SOFAS), Satisfaction Profile (SAT-P), and Borderline Personality Disorder Severity Index (BPDSI) were repeated at 6, 12, and 24 months. Statistical analysis was performed with the general linear model. Results showed that most of the differences between combined therapy and single pharmacotherapy at the end of the 32 weeks trial were maintained after 24 months follow-up. The addition of IPT-BPD to medication produced greater effects on BPD symptoms (impulsivity and interpersonal relationships) and quality of life (perception of psychological and social functioning) that endured after termination of psychotherapy. On the contrary, different effects on anxiety symptoms and affective instability were lost after 6 months.
Center for Personality Disorders, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126 Turin, Italy.
Paola
P
Bozzatello
Center for Personality Disorders, Department of Neuroscience, University of Turin, Via Cherasco 11, 10126 Turin, Italy. Electronic address: silvio.bellino@unito.it.
Silvio
S
Bellino
D000293:Adolescent; D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage*; D001007:Anxiety / Q000523:psychology; D001883:Borderline Personality Disorder / Q000523:psychology / Q000628:therapy*; D003131:Combined Modality Therapy; D003863:Depression / Q000523:psychology; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D007175:Impulsive Behavior; D007398:Interpersonal Relations; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011613:Psychotherapy / Q000379:methods*; D011788:Quality of Life / Q000523:psychology; D013995:Time; D016896:Treatment Outcome; D055815:Young Adult
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine
Borderline personality disorder; Combined therapy; Efficacy; Follow-up; Interpersonal psychotherapy; Long-term treatment